Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Doxepin Treatment Report
What is Doxepin?

Doxepin is a tricyclic antidepressant used to treat depression. Off label it is used as an analgesic for certain chronic and neuropathic pain and for anxiety. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Sleep problems 4 2
Other 3 0
Itching (pruritus) 2 0
Depression 2 0
Bladder problems 2 0
sleep 1 1

See all 13 patients currently taking Doxepin

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  daily 10 mg daily 20 mg daily 25 mg daily 50 mg daily 75 mg daily 100 mg daily 150 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Doxepin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%

See all 1 patient who’ve stopped taking Doxepin

Duration See details about how long patients take this treatment ▼

Currently Taking Doxepin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Doxepin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 17, 2010.